{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:47Z","timestamp":1786119467953,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/bsd.0b013e31819afdc4","type":"journal-article","created":{"date-parts":[[2010,1,30]],"date-time":"2010-01-30T02:27:18Z","timestamp":1264818438000},"page":"74-77","source":"Crossref","is-referenced-by-count":42,"title":["Tumor Necrosis \u03b1-blocking Agent (Etanercept)"],"prefix":"10.1097","volume":"23","author":[{"given":"Tosan","family":"Okoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhayl I.","family":"Tafazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Longworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Sell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210204","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0006-8993(95)00715-3","article-title":"Mechanism of tumour necrosis factor alpha hyperalgesia","volume":"692","author":"Watkins","year":"1995","journal-title":"Brain Res"},{"key":"R2-14-20210204","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0304-3959(95)00186-7","article-title":"Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states","volume":"63","author":"Watkins","year":"1995","journal-title":"Pain"},{"key":"R3-14-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(94)91566-0","article-title":"Characterization of cytokine-induced hyperalgesia","volume":"654","author":"Watkins","year":"1994","journal-title":"Brain Res"},{"key":"R4-14-20210204","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00007632-200104150-00007","article-title":"Selective inhibition of TNF-alpha prevents nucleus pulposus-induced thrombus formation, intra-neural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica","volume":"26","author":"Olmarker","year":"2001","journal-title":"Spine"},{"key":"R5-14-20210204","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00586-005-0028-1","article-title":"Outcome measures in spinal surgery quantified: excellent, good, fair, and poor in terms of patient-completed tools","volume":"15","author":"Tafazal","year":"2006","journal-title":"Eur Spine J"},{"key":"R6-14-20210204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/09674845.2002.11783656","article-title":"Tumour necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders","volume":"59","author":"Abuzakouk","year":"2002","journal-title":"Br J Biomed Sci"},{"key":"R8-14-20210204","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00006123-199909000-00034","article-title":"Nucleus pulposus-induced nerve root injury: the relationship between blood flow and nerve conduction velocity","volume":"45","author":"Otani","year":"1999","journal-title":"Neurosurgery"},{"key":"R9-14-20210204","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1097\/00007632-199812010-00008","article-title":"Tumour necrosis factor alpha and nucleus pulposus-induced nerve root injury","volume":"23","author":"Olmarker","year":"1998","journal-title":"Spine"},{"key":"R10-14-20210204","first-page":"170","article-title":"Peri-spinal TNF-alpha inhibition for discogenic pain","volume":"133","author":"Tobinick","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"R11-14-20210204","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/01.BRS.0000058944.38900.CE","article-title":"Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica","volume":"28","author":"Karppinen","year":"2003","journal-title":"Spine"},{"key":"R12-14-20210204","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1097\/01.brs.0000245873.23876.1e","article-title":"The treatment of disc herniation-induced sciatica with infliximab. One year follow-up results of FIRST II, a randomised controlled trial","volume":"31","author":"Korhonen","year":"2006","journal-title":"Spine"},{"key":"R13-14-20210204","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.anes.0000267518.20363.0d","article-title":"A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal Etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy","volume":"107","author":"Cohen","year":"2007","journal-title":"Anesthesiology"},{"key":"R14-14-20210204","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis: a randomised, controlled trial","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann Intern Med"},{"key":"R15-14-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumour necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N Engl J Med"},{"key":"R16-14-20210204","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2005.04.017","article-title":"Neuropathic pain: early spontaneous afferent activity is the trigger","volume":"116","author":"Xie","year":"2005","journal-title":"Pain"},{"key":"R17-14-20210204","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00007632-198303000-00003","article-title":"Lumbar disc herniation: a controlled, prospective study with ten years of observation","volume":"8","author":"Weber","year":"1983","journal-title":"Spine"},{"key":"R18-14-20210204","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa064039","article-title":"Surgery versus prolonged conservative treatment for sciatica","volume":"356","author":"Peul","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Journal of Spinal Disorders & Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BSD.0b013e31819afdc4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:05Z","timestamp":1786040345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024720-201002000-00014"}},"subtitle":["A Triple Blind Randomized Controlled Trial of its Use in Treatment of Sciatica"],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/bsd.0b013e31819afdc4","relation":{},"ISSN":["1536-0652"],"issn-type":[{"value":"1536-0652","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}